US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

65.09

-1.6800-2.52%

Volume:16.22K

Turnover:1.05M

Market Cap:92.74M

PE:- -

High:66.06

Open:66.06

Low:64.03

Close:66.77

52wk High:66.88

52wk Low:36.00

Shares:1.42M

Float Shares:1.42M

Volume Ratio:0.99

T/O Rate:1.14%

Dividend:0.65

Dividend Rate:1.00%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Natera Co-Founder, Director Sheena Jonathan Sells 6,000 Shares Worth $1.95 Million

Twist Bioscience CEO Emily Leproust Disposes of Common Shares Worth $2.5 Million

Natera (NTRA) Gets a Buy from Citi

Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million

Illumina Secures New Syndicated Credit Facility Agreement

Illumina - Enters Credit Agreement on August 13, 2026

Illumina Enters USD 1 Billion Five-Year Revolving Credit Facility with Bank of America-Led Lenders

Illumina - Credit Agreement Provides for $1 Bln Five-Year Revolving Credit Facility - SEC Filing

THOMSON REUTERS

Illumina - Credit Agreement Includes Option to Increase Commitments or Term Loans up to $500 Mln - SEC Filing

THOMSON REUTERS

Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Moderna Expands Respiratory Vaccine Pipeline With New RSV/hMPV Trial in Older Adults

Natera, Inc. : Citigroup Raises Target Price to $365 from $315

THOMSON REUTERS

Moderna Inc. Stock Rises 5.1%, Outperforms Peers

Illumina Prices $300 Million Notes Offering Due 2029

Natera, Inc. : Stephens Raises Target Price to $350 from $305

THOMSON REUTERS

Natera Partners with Kupando Therapeutics to Use Latitude ctDNA Test in Phase 1 Skin Cancer Trial

Natera to Support New Clinical Trial Assessing Ctdna Dynamics with Latitude™ in Advanced Skin Cancers

THOMSON REUTERS

Natera, Inc. : Piper Sandler Raises Target Price to $363.50 from $249

THOMSON REUTERS

Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares

Illumina Ajukan Form 3; Chief Legal Officer Julie Ann Coletti Laporkan Kepemilikan Manfaat Awal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GNOM/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":65.09,"timestamp":1787590978641,"preClose":66.77,"halted":0,"volume":16215,"delay":0,"changeRate":-0.02516100044930347,"floatShares":1424771,"shares":1424771,"eps":0,"marketStatus":"Trading","change":-1.68,"latestTime":"08-24 13:05:44 EDT","open":66.06,"high":66.06,"low":64.0301,"amount":1051979.176725,"amplitude":0.030401,"askPrice":65.16,"askSize":200,"bidPrice":64.85,"bidSize":20,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":66.77,"sharesOutstanding":1094672,"nav":66.56,"aum":94832765.15,"dividendRate":0.009951,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":66.06,"preClose":66.77,"latestTime":"09:29 EDT","volume":502,"amount":33166.99944,"timestamp":1787578199999,"change":-0.71,"changeRate":-0.010634,"amplitude":0.001647},"postHourTrading":{"tag":"盘后","latestPrice":65.99,"preClose":66.77,"latestTime":"19:30 EDT","volume":120,"amount":7931.95,"timestamp":1787355006727,"change":-0.78,"changeRate":-0.011682,"amplitude":0.011682},"volumeRatio":0.991785,"impliedVol":0.3306,"impliedVolPercentile":0.844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1424771,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.991785,"shares":1424771,"dividePrice":0.6477,"high":66.06,"amplitude":0.030401,"preClose":66.77,"low":64.0301,"week52Low":36,"pbRate":"--","week52High":66.88,"institutionHeld":0,"latestPrice":65.09,"committee":-0.818182,"eps":0,"divideRate":0.009951,"volume":16215,"delay":0,"ttmEps":0,"open":66.06,"prevYearClose":45.4562,"prevWeekClose":66.77,"prevMonthClose":54.17,"prevQuarterClose":56.834,"fiveDayClose":59.09,"twentyDayClose":53.6914,"sixtyDayClose":49.5125},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659812795","title":"Natera Co-Founder, Director Sheena Jonathan Sells 6,000 Shares Worth $1.95 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659812795","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659812795?lang=en_us&edition=fundamental","pubTime":"2026-08-15 09:35","pubTimestamp":1786757742,"startTime":"0","endTime":"0","summary":"Natera co-founder, Director Sheena Jonathan sells 6,000 shares worth $1.95 millionNatera director and co-founder Sheena Jonathan sold 6,000 common shares on Aug. 10, 2026 at USD 325.32 each.Directly h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260815:nNDL1dBDL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Co-Founder, Director Sheena Jonathan Sells 6,000 Shares Worth $1.95 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","LU2065171402.SGD","LU2065169927.USD","LU2065170008.USD","LU2264538146.SGD","LU0106261612.USD","GNOM","LU0963586101.USD","LU0345770308.USD","LU1988902786.USD","NTRA","LU0012050646.USD","LU2324357040.USD","LU2065731478.USD","LU1064131342.USD","LU0053671581.USD","LU2065171311.SGD","BK4139","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126777","title":"Twist Bioscience CEO Emily Leproust Disposes of Common Shares Worth $2.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126777","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126777?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:09","pubTimestamp":1786738148,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO Emily Leproust disposes of common shares worth $2.5 millionTwist Bioscience CEO Emily M. Leproust exercised stock options for 19,952 shares on Aug. 12, 2026 at USD 26.66.She sold ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL2Cx15Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience CEO Emily Leproust Disposes of Common Shares Worth $2.5 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","TWST","BK4585","WDNA","GNOM","BK4139","BK4588","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659729143","title":"Natera (NTRA) Gets a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2659729143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659729143?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:57","pubTimestamp":1786705032,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick B Donnelly from Citi maintained a Buy rating on Natera, with a price target of $365.00. According to TipRanks, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/natera-ntra-gets-a-buy-from-citi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/natera-ntra-gets-a-buy-from-citi-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065169927.USD","LU1064131342.USD","LU2065171402.SGD","LU0345770308.USD","LU2065731478.USD","LU0106261612.USD","LU0053671581.USD","LU0012050646.USD","LU2264538146.SGD","BK4139","LU0345770993.USD","LU2065171311.SGD","GNOM","LU1988902786.USD","LU0963586101.USD","NTRA","LU2324357040.USD","LU2065170008.USD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659719596","title":"Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659719596","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659719596?lang=en_us&edition=fundamental","pubTime":"2026-08-14 07:21","pubTimestamp":1786663307,"startTime":"0","endTime":"0","summary":"Guardant Health Chief People Officer Terilyn Monroe disposes of common shares worth $7.61 millionGuardant Health Chief People Officer Terilyn J. Monroe cut her direct common stock stake to 22,979 shar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1rsYJl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4535","HELX","LU0889565916.HKD","GH","PTH","LFSC","GDOC","LU0320765992.SGD","BK4551","BK4588","GNMX","GNOM","BK4585","EKG","FFOX","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160249","title":"Illumina Secures New Syndicated Credit Facility Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160249","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160249?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:58","pubTimestamp":1786654723,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Illumina ( ($ILMN) ). On August 13, 2026, Illumina, Inc. entered into a credit agreement with a syndicate of le...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/illumina-secures-new-syndicated-credit-facility-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/illumina-secures-new-syndicated-credit-facility-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ILMN","BK4548","BK4588","LU0029874061.USD","BK4585","BK4121","LU0128526141.USD","GNMX","GNOM","BK4535","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659716090","title":"Illumina - Enters Credit Agreement on August 13, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659716090","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659716090?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:58","pubTimestamp":1786654702,"startTime":"0","endTime":"0","summary":"BRIEF-Illumina - Enters Credit Agreement On August 13, 2026Aug 13 -Illumina IncILMN.O:ILLUMINA - ENTERS CREDIT AGREEMENT ON AUGUST 13, 2026 - SEC FILINGILLUMINA - CREDIT AGREEMENT PROVIDES FOR $1 BILLION FIVE-YEAR REVOLVING CREDIT FACILITY - SEC FILINGILLUMINA - CREDIT AGREEMENT INCLUDES OPTION TO INCREASE COMMITMENTS OR TERM LOANS UP TO $500 MILLION - SEC FILINGFurther company coverage:ILMN.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GNOM","BK4535","BK4534","BK4121","ILMN","LU0128526141.USD","LU0029874061.USD","GNMX","BK4548","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167148","title":"Illumina Enters USD 1 Billion Five-Year Revolving Credit Facility with Bank of America-Led Lenders","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167148","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167148?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:29","pubTimestamp":1786652993,"startTime":"0","endTime":"0","summary":"Illumina enters USD 1 billion five-year revolving credit facility with Bank of America-led lendersIllumina entered a new senior unsecured five-year revolving credit facility of $1 billion on Aug. 13, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL4XmN3n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYF","IE00B19Z3581.USD","BK4588","LU0052756011.USD","VFH","LU0098860793.USD","XLF","LU0787776722.HKD","LU0306807586.USD","IE00BLSP4239.USD","LU1201861165.SGD","LU0149725797.USD","LU1162221912.USD","LU0130102774.USD","LU0683600562.USD","LU1280957306.USD","LU2129689514.USD","LU1267930227.SGD","UYG","LU1894683348.USD","LU0128526141.USD","FTXO","BK4548","KBWB","LU0320765489.SGD","LU2133065610.SGD","TFNS","FNCL","BK4585","BK4559","ILMN","LU0321505439.SGD","LU1718418525.SGD","LU1074936037.SGD","LU1894683264.USD","GNOM","GNMX","BAC","LU0256863902.USD","LU0310800965.SGD","IYG","LU2265009873.SGD","LU0417517546.SGD","LU0170899867.USD","IE00BFXG1179.USD","LU0053666078.USD","LU1363072403.SGD","LU0029874061.USD","LU1291159041.SGD","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659673001","title":"Illumina - Credit Agreement Provides for $1 Bln Five-Year Revolving Credit Facility - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659673001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659673001?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:21","pubTimestamp":1786652505,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1N2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0128526141.USD","BK4535","BK4121","GNMX","GNOM","ILMN","LU0029874061.USD","BK4548","BK4534","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167664","title":"Illumina - Credit Agreement Includes Option to Increase Commitments or Term Loans up to $500 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167664","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167664?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:21","pubTimestamp":1786652505,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1N2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4588","BK4534","BK4121","GNMX","ILMN","BK4585","GNOM","BK4548","LU0029874061.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162947","title":"Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162947","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162947?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"clinical trial were presented at the 2026 European Hematology Association.  Annual Meeting. Data presented reinforced vispa-cel is the only. single-dose, off-the-shelf therapy to demonstrate deep and durable. responses on par with autologous CAR-T cell therapies in second-line . large B cell lymphoma . Efficacy and safety data in 2L LBCL. patients who had received a single dose of 80 million optimized vispa-cel. -- Optimized vispa-cel is defined as cells from a donor younger than 30. years old with at least two matched human leukocyte antigen  alleles. between patient and donor. The 27-patient subgroup best represents the. treatment regimen and patient population for Caribou's planned ANTLER-3. -- Caribou previously reached alignment with the U.S. Food and Drug. Administration  regarding its planned ANTLER-3 pivotal phase 3. clinical trial design, which is expected to be a randomized, control","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","FBT","BK4195","CNCR","BK4211","MEDX","CAR","GNOM","CRBU","SYNB","BK4161","NVIB","BK4539","LFSC","GDOC","LD","HYLG","BK4585","CR","BK4022","IDNA","ORR","PFS","IBBQ","TBXU","BK4230","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166082","title":"Moderna Expands Respiratory Vaccine Pipeline With New RSV/hMPV Trial in Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166082","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166082?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:30","pubTimestamp":1786638638,"startTime":"0","endTime":"0","summary":"Moderna ($MRNA) announced an update on their ongoing clinical study. ModernaTX, Inc. has launched a new early-stage trial called “A Phase 1, Random...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/moderna-expands-respiratory-vaccine-pipeline-with-new-rsv-hmpv-trial-in-older-adults?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/moderna-expands-respiratory-vaccine-pipeline-with-new-rsv-hmpv-trial-in-older-adults?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGHT","BK4501","BK4585","BK4534","BK4551","BK4532","GNOM","BK4139","IDNA","MRNX","BK4533","BK4588","BK4568","WDNA","BK4548","MRNA","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659153712","title":"Natera, Inc. : Citigroup Raises Target Price to $365 from $315","url":"https://stock-news.laohu8.com/highlight/detail?id=2659153712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659153712?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:33","pubTimestamp":1786617184,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171311.SGD","LU2264538146.SGD","LU2065171402.SGD","HELX","LU0345770993.USD","LU0053671581.USD","LU0963586101.USD","LU0106261612.USD","LU0345770308.USD","NTRA","LU1064131342.USD","LU1988902786.USD","BK4139","GNOM","LU2065169927.USD","LU2065170008.USD","LU2065731478.USD","LU0012050646.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188699","title":"Moderna Inc. Stock Rises 5.1%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188699","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188699?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:34","pubTimestamp":1786566840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 5.1% to $63.67 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 26,588.49 and the Dow Jones Industrial Average remaining mostly unchanged at 53,770.27.This was the stock's fourth consecutive day of gains.Moderna Inc. closed 25.6% below its 52-week high of $85.60, which the company reached on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.4% to $260.86, Pfizer Inc. fell 1.2% to $26.31, and Gilead Sciences Inc. rose 0.07% to $135.87.Trading volume totaled 6.0 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","GILD","BIB","BK4551","LU1037948541.HKD","IDNA","WDNA","MRNX","MEDI","BK4139","IBB","LU0965508806.USD","SG9999015978.USD","LU2087621335.USD","IE00BSNM7G36.USD","LU0823416689.USD","IE00B19Z3581.USD","LU1430594728.SGD","LGHT","LU1674673428.USD","BK4501","LU2324357040.USD","BK4550","LU0889565916.HKD","LU1023059063.AUD","LU1037948897.HKD","LU1585245621.USD","MRNA","TMED","BMED","LU1674673691.USD","IE00BKVL7J92.USD","LU1057294990.SGD","IE00BZ1G4Q59.USD","LU0882574055.USD","BBH","LU1066051498.USD","GNOM","LU1061106388.HKD","BK4585","LU2112291526.USD","BK4588","LU1934455194.USD","MRNY","BK4566","LU0289739699.SGD","IE0002270589.USD","TBXU","BK4532","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972920","title":"Illumina Prices $300 Million Notes Offering Due 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972920","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972920?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:06","pubTimestamp":1786536384,"startTime":"0","endTime":"0","summary":"Illumina prices $300 million notes offering due 2029Illumina priced USD 300 million of 4.95% notes due 2029 under an underwriting agreement led by J.P. Morgan, Citigroup.Closing expected Aug. 17, subj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL4K9VGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU2360032135.SGD","BK4535","FTXO","LU0203345920.USD","LU0310800965.SGD","LU0072461881.USD","LU0314106906.USD","BK4585","LU2462157665.USD","BK4504","LU0980610538.SGD","LU1668664300.SGD","LU2236285917.USD","LU0106831901.USD","LU1162221912.USD","LU1201861249.SGD","LU1244550221.USD","LU2125154935.USD","ILMN","IE00BSNM7G36.USD","LU0029874061.USD","GNMX","LU1506573853.SGD","LU0098860793.USD","IYF","BK4588","BK4121","LU1074936037.SGD","BK4548","BK4207","LU0477156953.USD","LU0648001328.SGD","LU2125154778.USD","LU1267930227.SGD","TFNS","LU0170899867.USD","LU1791807156.HKD","LU2417539215.USD","LU0162691827.USD","LU1244550577.SGD","LU0203347892.USD","LU2456880835.USD","GNOM","LU0128526141.USD","LU0320765646.SGD","BK4566","LU0052756011.USD","LU1366192091.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658118976","title":"Natera, Inc. : Stephens Raises Target Price to $350 from $305","url":"https://stock-news.laohu8.com/highlight/detail?id=2658118976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658118976?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:21","pubTimestamp":1786530064,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490FB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065731478.USD","LU1988902786.USD","HELX","GNOM","BK4139","LU0106261612.USD","LU0012050646.USD","LU0345770993.USD","LU0345770308.USD","NTRA","LU2065171311.SGD","LU2065169927.USD","LU2324357040.USD","LU2065170008.USD","LU0963586101.USD","LU1064131342.USD","LU0053671581.USD","LU2065171402.SGD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658975282","title":"Natera Partners with Kupando Therapeutics to Use Latitude ctDNA Test in Phase 1 Skin Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658975282","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658975282?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:01","pubTimestamp":1786528893,"startTime":"0","endTime":"0","summary":"Natera partners with Kupando Therapeutics to use Latitude ctDNA test in Phase 1 skin cancer trialNatera entered a collaboration with Kupando Therapeutics to support a Phase 1 trial of immunotherapy ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLbT5KLV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0963586101.USD","NTRA","LU2065731478.USD","LU2065169927.USD","BK4139","LU0012050646.USD","LU0053671581.USD","LU1064131342.USD","LU2264538146.SGD","LU2065171311.SGD","LU0345770308.USD","LU0345770993.USD","HELX","LU1988902786.USD","LU2324357040.USD","LU0106261612.USD","GNOM","LU2065170008.USD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658975416","title":"Natera to Support New Clinical Trial Assessing Ctdna Dynamics with Latitude™ in Advanced Skin Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658975416","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658975416?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:00","pubTimestamp":1786528800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA74PDL6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0963586101.USD","BK4139","LU0106261612.USD","LU0012050646.USD","LU0053671581.USD","LU0345770308.USD","LU2065171311.SGD","GNOM","LU1064131342.USD","LU2065171402.SGD","LU2324357040.USD","NTRA","LU1988902786.USD","LU2065731478.USD","LU0345770993.USD","LU2065169927.USD","HELX","LU2065170008.USD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658975588","title":"Natera, Inc. : Piper Sandler Raises Target Price to $363.50 from $249","url":"https://stock-news.laohu8.com/highlight/detail?id=2658975588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658975588?lang=en_us&edition=fundamental","pubTime":"2026-08-12 17:49","pubTimestamp":1786528145,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490C2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU0053671581.USD","LU0345770308.USD","LU2065170008.USD","LU0963586101.USD","LU1988902786.USD","LU0345770993.USD","LU0012050646.USD","LU2065169927.USD","LU2264538146.SGD","LU2065171402.SGD","LU0106261612.USD","HELX","NTRA","LU2065731478.USD","BK4139","GNOM","LU2065171311.SGD","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658949165","title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949165","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949165?lang=en_us&edition=fundamental","pubTime":"2026-08-12 06:23","pubTimestamp":1786487005,"startTime":"0","endTime":"0","summary":"Guardant Health Chief Commercial Officer Chris Freeman disposes of $ 10.75 million in common sharesGuardant Health Chief Commercial Officer Chris Freeman exercised stock options for 63,605 shares on A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4khYKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","GDOC","LU0109394709.USD","BK4585","EKG","FFOX","PTH","GNMX","GNOM","HELX","BK4551","LU0889565916.HKD","BK4535","LU0320765992.SGD","BK4588","GH","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658283943","title":"Illumina Ajukan Form 3; Chief Legal Officer Julie Ann Coletti Laporkan Kepemilikan Manfaat Awal","url":"https://stock-news.laohu8.com/highlight/detail?id=2658283943","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658283943?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:28","pubTimestamp":1786480129,"startTime":"0","endTime":"0","summary":"Illumina ajukan Form 3; Chief Legal Officer Julie Ann Coletti laporkan kepemilikan manfaat awalIllumina mengajukan Form 3 untuk Julie Ann Coletti sebagai Chief Legal Officer, dengan tanggal kejadian 0","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL1D0fxf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GNOM","BK4535","LU0128526141.USD","BK4534","GNMX","ILMN","BK4548","BK4588","LU0029874061.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":10,"totalSize":205,"code":"91000000","status":"200"}]}}